Chapel Hill, NC, United States of America

Robin Parish Hyde-Deruyscher

This inventor holds 9 USPTO granted patents, plus 1 CIPO patent and 2 EPO patents. Top assignees: Emergo Therapeutics, Inc., Biogen Ma Inc., Emergo Therpeutics, Inc.. Active years: 2003-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Robin Parish Hyde-Deruyscher. Retrieved from https://idiyas.com/inventor/robin-parish-hyde-deruyscher

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9

% Patents Active = 100.0

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 2 (Patent Applications = 3)

Average Co-Inventor Count = 2.6

ph-index = 4

Forward Citations = 61(Granted Patents)

Company Filing History:

5 out of 5

Emergo Therapeutics, Inc.

Emergo Therpeutics, Inc.

Years Active: 2003-2023

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11753668 - Copper supplementation for control of glycosylation in mammalian cell culture process (2023-09-12),

2. 11478463 - Mast cell stabilizers for treatment of chronic inflammatory conditions (2022-10-25),

3. 11268119 - Copper supplementation for control of glycosylation in mammalian cell culture process (2022-03-08),

4. 11072648 - Mast cell stabilizers for treatment of fever (2021-07-27),

5. 10787502 - Mast cell stabilizers for treatment of hypercytokinemia and viral infection (2020-09-29),

6. 10501527 - Mast cell stabilizers for treatment of hypercytokinemia and viral infection (2019-12-10),

7. 10494420 - Mast cell stabilizers for treatment of hypercytokinemia and viral infection (2019-12-03),

8. 10160796 - Mast cell stabilizers for treatment of hypercytokinemia and viral infection (2018-12-25),

9. 6617114 - Identification of drug complementary combinatorial libraries (2003-09-09),

Title: Robin Parish Hyde-Deruyscher: Innovator in Cell Culture and Inflammatory Treatment

Introduction

Robin Parish Hyde-Deruyscher is a notable inventor based in Chapel Hill, NC (US). He has made significant contributions to the field of biotechnology, particularly in cell culture processes and treatments for chronic inflammatory conditions. With a total of 9 patents to his name, Hyde-Deruyscher's work has had a meaningful impact on the industry.

Latest Patents

Hyde-Deruyscher's latest patents include innovative solutions for enhancing cell culture processes. One of his notable inventions is a method for copper supplementation in cell culture media. This invention aims to control glycosylation in mammalian cell culture processes, which is crucial for the production of recombinant proteins. Another significant patent involves the use of mast cell stabilizers for treating chronic inflammatory conditions. This invention outlines methods and compositions that utilize mast cell stabilizing agents to alleviate such conditions.

Career Highlights

Throughout his career, Hyde-Deruyscher has worked with prominent companies in the biotechnology sector. He has been associated with Emergo Therapeutics, Inc. and Biogen MA Inc., where he has contributed to various innovative projects. His expertise in cell culture and inflammatory treatments has positioned him as a valuable asset in these organizations.

Collaborations

Hyde-Deruyscher has collaborated with several professionals in his field, including Nancy Harlan Hyde-DeRuyscher and Elicia Kristine Hyde-DeRuyscher. These collaborations have likely enriched his research and development efforts, leading to advancements in his patented technologies.

Conclusion

Robin Parish Hyde-Deruyscher is a distinguished inventor whose work in biotechnology has led to significant advancements in cell culture and treatment methodologies. His contributions continue to influence the field and pave the way for future innovations.

Profile summary based on public USPTO records.